DTCAMD, a disease-associated truncated form of CRYAB in neovascular age-related macular degeneration: a potential driver of subretinal fibrosis
Eunhye Yu, Sun Mi Gu, Jonghwa Jin, Jung Kee Min, Jaesuk Yun
This study identifies a truncated form of CRYAB, DTCAMD, as a potential therapeutic target for subretinal fibrosis in nAMD.
bioRxiv · Oct 12, 2026 · PreprintPathology